3 documents found, page 1 of 1
Prevalence, treatment, and control of dyslipidemia in diabetic participants of ...
Martins,Nestor S.; Mello,Daniel S.S.; Barreto,Joaquim; Soares,Alexandre A.S.; Breder,Ikaro; Cunha,Jessica; Nadruz,Wilson; Coelho Filho,Otavio R.SUMMARY OBJECTIVE Diabetes is one of the leading causes of cardiovascular mortality. Over the last years, mortality has decreased significantly, more in individuals with diabetes than in healthy ones. That is mostly due to the control of other cardiovascular risk factors. The objective of our study was to analyze the dyslipidemia control in two diabetes cohorts. METHODS Patients from two distinct cohorts were s...
Intensive treatment of hyperglycemia in the acute phase of myocardial infarctio...
Negreiros,Paulo H.; Bau,Adriana; Nadruz,Wilson; Coelho Filho,Otavio R.; Matos-Souza,José Roberto; Coelho,Otavio R.; Sposito,Andrei C.SUMMARY INTRODUCTION In acute myocardial infarction (AMI), each 18 mg/dl (1 mmol/L) increment is associated with a 3% increase in mortality rates. All strategies applied for reducing blood glucose to this date, however, have not presented encouraging results. METHODOLOGY We searched the Medline (PubMed) and Cochrane Library databases for randomized clinical trials (RCTs) from 1995 to 2017 that used the intensiv...
Diabetic cardiomyopathy: factual or factoid?
Quinaglia,Thiago; Oliveira,Daniela C.; Matos-Souza,José Roberto; Sposito,Andrei C.SUMMARY Although long ago described, there is no established consensus regarding the real existence of Diabetic Cardiomyopathy (CMPDM). Due to its complex pathophysiology, it has been difficult for clinical and experimental research to establish clear connections between diabetes mellitus (DM) and heart failure (HF), as well as to solve the mechanisms of the underlying myocardial disease. However, the epidemiol...